Natriuretic peptides suppress protein kinase C activity to reduce evoked dopamine efflux from pheochromocytoma (PC12) cells

Endocrinology

Volumn 144, Issue 1, 2003, Pages 94-100

  Trachte, George J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHELERYTHRINE; DOPAMINE; NATRIURETIC PEPTIDE TYPE C; PEPTIDE DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; NEUROMODULATION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; DOPAMINE; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE, C-TYPE; PC12 CELLS; PHENANTHRIDINES; PROTEIN KINASE C; RATS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; STAUROSPORINE;

EID: 0037225484     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220494     Document Type: Article

References (38)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H 1981 A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94
2. Flynn TG, de Bold ML, de Bold AJ 1983 The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 117:859-865
3. Sudoh T, Kangawa K, Minamino N, Matsuo H 1988 A new natriuretic peptide in porcine brain. Nature 332:78-81
4. Sudoh T, Minamino N, Kangawa K, Matsuo H 1990 C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168:863-870
5. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG 1988 Isolation and structural analysis of "urodilatin," a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66:752-759
6. Chinkers M, Garbers DL, Chang M-S, Lowe DG, Chin H, Goeddel DV, Schulz S 1989 A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338:78-83
7. Chang M-s, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV 1989 Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341:68-72
8. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV 1991 Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252:120-123
9. Suga S-I, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Kambayashi Y, Inouye K, Imura H 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and C-type natriuretic peptide. Endocrinology 130:229-239
10. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA 1987 Physiological role of silent receptors of atrial natriuretic factor. Science 238:675-678
11. Porter JG, Arfsten A, Fuller F, Miller JA, Gregory LC, Lewicki JA 1990 Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem Biophys Res Commun 171:796-803
12. Anand-Srivastava MB, Sairam MR, Cantin M 1990 Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. J Biol Chem 265:8566-8572
13. Resink TJ, Scott-Burden T, Baur U, Jones CR, Buhler FR 1988 Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth-muscle cells. Eur J Biochem 172:499-505
14. Prins BA, Weber MJ, Hu R-M, Pedram A, Daniels M, Levin ER 1996 Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. J Biol Chem 271:14156-14162
15. Drewett JG, Ziegler RJ, Trachte GJ 1990 Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells. J Pharmacol Exp Ther 255:497-503
16. Rodriguez-Pascual F, Miras-Portugal MT, Torres M 1996 Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: Inhibitory role mediated by cyclic GMP-dependent protein kinase. Mol Pharmacol 49:1058-1070
17. Nakamaru M, Inagami T 1986 Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries. Eur J Pharmacol 123:459-461
18. Trachte GJ, Kanwal S, Elmquist BJ, Ziegler RJ 1995 C-type natriuretic peptide neuromodulates via "clearance" receptors. Am J Physiol 268:C978-C984
19. Trachte GJ 2000 Depletion of natriuretic peptide C receptors eliminates inhibitory effects of C-type natriuretic peptide on evoked neurotransmitter efflux. J Pharmacol Exp Ther 294:210-215
20. Kanwal S, Lowe DG, Trachte GJ 1999 Intracellular fragments of the natriuretic peptide receptor-C (NPR-C) attenuate dopamine efflux. Endocrinology 140:1118-1124
21. Kanwal S, Elmquist BJ, Trachte GJ 1997 Atrial natriuretic peptide inhibits evoked catecholamine release by altering sensitivity to calcium. J Pharmacol Exp Ther 283:426-433
22. Harris KM, Kongsamut S, Miller RJ 1986 Protein kinase C mediated regulation of calcium channels in PC-12 pheochromocytoma cells. Biochem Biophys Res Commun 134:1298-1305
23. 2+ channels in two secretory cell lines, PC12 and RINm5F. J Biol Chem 261:32-35
24. 2+-dependent and -independent release of neurotransmitters from PC12 cells: A role for protein kinase C activation? J Cell Biol 99:628-638
25. Portzehl H, Caldwell PC, Ruegg JC 1964 The dependence of contraction and relaxation of muscle fibres from the crab Squinado maia on the internal concentration of free calcium ions. Biochim Biophys Acta 79:581-591
26. Tamm C, Lang U, Vallotton NB 1990 Effects of atrial natriuretic factor on angiotensin II and phorbol ester-stimulated protein kinase C and prostacyclin production in cultured rat aortic smooth muscle cells. Endocrinology 126:658-665
27. Sugimoto T, Kikkawa R, Haneda M, Shigeta 1993 Atrial natriuretic peptide inhibits endothelin-1-induced activation of mitogen-activated protein kinase in cultured rat mesangial cells. Biochem Biophys Res Commun 195:72-78
28. Barnett RL, Ruffini L, Ramsammy L, Pasmantier R, Friedlaender MM, Nord EP 1995 cGMP antagonizes angiotensin-mediated phophatidylcholine hydrolysis and C kinase activation in mesangial cells. Am J Physiol 268:C376-C381
29. Kumar R, Cartledge WA, Lincoln TM, Pandey KN 1997 Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Hypertension 29:414-421
30. Pandey KN, Inagami T, Girard PR, Kuo JF, Misono KS 1987 New signal transduction mechanisms of atrial natriuretic factor: Inhibition of phosphorylation of protein kinase C and A 240 kDa protein in adrenal cortical plasma membrane by cGMP dependent and independent mechanisms. Biochem Biophys Res Commun 148:589-595
31. Sauro MD, Fitzpatrick DF 1990 Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle. Pept Res 3:138-141
32. Pocotte SL, Frye RA, Senter RA, TerBush DR, Lee SA, Holz RW 1985 Effects of phorbol ester on catecholamine secretion and protein phosphorylation in adrenal medullary cell cultures. Proc Natl Acad Sci USA 82:930-934
33. 2+ stimulated catecholamine release from α-toxin-permeabilized PC12 cells: Biochemical evidence for exocytosis and its modulation by protein kinase C and G proteins. Biochemistry 26:7842-7848
34. Meldolesi J, Gatti G, Ambrosini A, Pozzan T, Westhead EW 1988 Second-messenger control of catecholamine release from PC12 cells. Biochem J 255:761-768
35. Allgaier C, Hertting G 1986 Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-dibutyrate. Naunyn Schmiedeberg Arch Pharmacol 334:218-221
36. Matthies HJG, Palfrey C, Hirning LD, Miller RJ 1987 Down regulation of protein kinase C in neuronal cells: Effects on neurotransmitter release. J Neurosci 7:1198-1206
37. + but not by muscarine in rat adrenal medulla. Nature 321:698-700
38. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE 1989 Potent selective inhibitors of protein kinase C. FEBS Lett 259:61-63